Vion Pharmaceuticals Inc.
(MM)
   
To register click here

Vion Pharmaceuticals Stock Price VION

Company Description : A development stage pharmaceutical company, which is engaged in the development of products for the treatment of cancer. url: www.vionpharm.com

Name:
Vion Pharmaceuticals Inc. (MM)
Symbol:
NASDAQ:VION
Stock Market:
NASDAQ Stock Market
Type:
Common Stock
ISIN:
Description:
 Change (p)Change (%)CurBidAskHighLowOpenVolumeTimeA
0.0010.120.8510.850.860.860.80.8108399013:40:57
To register Click hereRegister for free Vion Pharmaceuticals stock prices.

Vion Pharmaceuticals Announces Presentation of Data of Cloretazine(R) (VNP40101M) in Elderly Patients with High-Risk Myelodyspla : NEW HAVEN, Conn., June 13 /PRNewswire-FirstCall/ -- VION PHARMACEUTICALS, INC. (NASDAQ:VION) today announced that data from a previously conducted Phase II trial of its lead anticancer agent Cloretazine(R) (VNP40101M) in...

Free Vion Pharmaceuticals Stock Charts

Vion Pharmaceuticals Historical Stock Chart
Vion Pharmaceuticals Historical Stock Chart
Vion Pharmaceuticals Monthly Stock Chart
Vion Pharmaceuticals Monthly Stock Chart
Vion Pharmaceuticals Intraday stock chart
Vion Pharmaceuticals Intraday stock chart

To register Click hereRegister for FREE streaming stock charts featuring overlays, annotations and more than 80 different studies including Level 2 Scope and Average True Range.

Get the Latest Vion Pharmaceuticals stock Price, quotes, trades and FREE Vion Pharmaceuticals stock charts, company information, annual reports, market news and announcements from ADVFN. We offer Intraday and historical stock prices for Vion Pharmaceuticals (VION) and other NASDAQ Stock Market listed companies as well as company financials, Level 2 Data and the latest investor information from our stock market Message Boards.

Vion Pharmaceuticals News & Message Board Discussion

Latest Vion Pharmaceuticals News Headlines
DateTimeSource
Headline
06/13/20083:30AMPRNUSVion Pharmaceuticals Announces Presentation of Data of Cloretazine(R) (VNP40101M) in Elderly Patients with High-Risk Myelodyspla
06/02/20083:06PMPRNUSVion Pharmaceuticals Announces Presentation of Interim Data from Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Acute M
06/02/20089:20AMPRNUSBeaconEquity.com Issues TraderNotes on Biotechnology Stocks: TPIM, RXII, VION, CUR, AMGN, GILD, BIIB, GENR
06/02/20087:30AMPRNUSVion Pharmaceuticals Announces Presentation of Data from Phase III Trial of Cloretazine(R) (VNP40101M) and Cytarabine in Relapse
05/30/20088:00AMPRNUSVion Pharmaceuticals to Present Clinical Data on Cloretazine(R) (VNP40101M) at the ASCO(R) Annual Meeting
05/08/20088:00AMPRNUSVion Pharmaceuticals Announces Initiation of Clinical Trial of Cloretazine(R) (VNP40101M) in Combination with Cytarabine
05/08/20087:45AMPRNUSVion Pharmaceuticals to Appeal Nasdaq Delisting
05/06/20088:00AMPRNUSVion Pharmaceuticals to Host Conference Call to Discuss 2008 First Quarter Financial Results
05/05/20084:30PMPRNUSVion Reports 2008 First Quarter Results
04/15/20084:30PMPRNUSVion Pharmaceuticals Files Plan With Nasdaq
03/26/20088:00AMPRNUSVion Pharmaceuticals Receives Nasdaq Notice
03/07/20088:00AMPRNUSVion Pharmaceuticals Regains NASDAQ Listing Compliance
Latest Message Board Discussions
DateTimeSource
TitleMore
11/21/20067:02PMFreeVion Pharmaceuticals UP 13% on trial data 

Vion Pharmaceuticals Company Information

 Sector  Turnover (m)  Profit (m)  EPS - Basic  PE ratio  Mkt Cap (m)  NMS 
  0.00 0.00   0.0 N/A
To register Click hereRegister for FREE access to the latest Vion Pharmaceuticals company information and fundamental data for other USA Common Stock companies. More than 100 separate statistics including accounts payable / sales and inventory / sales.

Latest Vion Pharmaceuticals Stock Trade

 Type  Size  Price  Date  Tr.Time  Units 
  100 0.851 07/25/2008 1:40PM USD


 



PLUS quotes are live. NYSE and AMEX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions :: Contact Us :: Request an Exchange :: Affiliate Scheme
Copyright1999-2008 ADVFN PLC. Copyright and limited reproduction :: Privacy Policy :: Investment Warning :: Advertise with us :: Data accreditations :: Investor Relations :: Press office :: Jobs
ADDITIONAL SERVICES AVAILABLE FROM ADVFN
Upgrade - Click here for more information on ADVFN premium services Money Words - ADVFN Financial Glossary Investor Training ADVFN Financial Bookshop Online Training Academy
32 site:2us nasdaq vion080725 14:08 Stock Message Boards ( 2001 | 2002 | 2003 | 2004 | 2005 | 2005 | 2007 )